Details
Percentage of LTC residents not living with psychosis who were given antipsychotic medication
-
In Ontario long-term care homes, antipsychotic medications play a crucial role in treating behavioral symptoms, such as agitation and aggression, that are associated with psychosis or dementia. However, the use of antipsychotic medications has become a subject of controversy, both within the province and globally, due to their potential adverse effects, which include sedation, increased fall risk, and a slightly elevated risk of death. Family members of residents are often concerned when they witness these effects – loved ones struggling to communicate or experiencing prolonged periods of drowsiness – but, for some residents, not taking these medications can lead to behaviours that pose risks to themselves and others around them.
Key Resources
- Choosing Wisely Canada Antipsychotics Toolkit
- Appropriate Use of Antipsychotics (AUA) approach by Healthcare Excellence Canada
- Ontario Health Quality Standards: Behavioural Symptoms of Dementia—Care for Patients in Hospitals and Residents in Long-Term Care Homes
- Centre for Effective Practice: Antipsychotics in Dementia Care tool
Change Ideas
-
Collect and monitor current resident medication use data
- Review medication use data from the home and from pharmacy providers (e.g., indications, new starts, PRNs, administration rates, summary of responsive behaviours, interventions)
- Sign up for long-term care practice reports for antipsychotics data and change ideas for reducing the use of antipsychotic medications
Ontario Health MyPractice: Long-Term Care
Establish a regular medication review process
- Use a simple, standardized medication review process
Alberta Health Services: Pharmacologic Restraint Management Worksheet - Upon admission of new residents, conduct a comprehensive assessment to determine if antipsychotic medications are being used and whether there is an appropriate diagnosis that justifies their use
- Consider using an interprofessional approach – involving behaviour support leads, physicians, pharmacists, nurses, and personal support workers – for monthly and quarterly medication reviews
- Review the charts of residents that trigger the RAI (Resident Assessment Instrument) Indicator Code: DRG01 to assess appropriate use of antipsychotics
Develop and update individual behaviour care plans
- For each resident, evaluate whether any potential contributors to behavioural and psychological symptoms of dementia are present (e.g., conduct an assessment for delirium, a general medical and mental health history, a pain assessment, a medication review, a substance use review, and hearing and vision assessments)
P.I.E.C.E.S. assessment tool - A practical, effective approach to change and continuous improvement - Use standardized assessment tools to inform care plans (e.g., Dementia Observation System, Cohen-Mansfield Agitation Inventory, Kingston Standardized Behavioural Assessment)
Behavioural Supports Ontario Dementia Observation System
Kingston Standardized Behavioural Assessment
Cohen-Mansfield Agitation Inventory - Incorporate nonpharmacological interventions into care plans for residents who are being treated with antipsychotics or displaying responsive behaviours
- Engage residents, families, and care partners in discussions about antipsychotic medications, responsive behaviours, and care with nonpharmacological interventions
Distribute factsheets or information pamphlets
Choosing Wisely Canada: Treating Disruptive Behaviour in People with Dementia: Antipsychotic drugs are usually not the best choice
- How Antipsychotic Medications are Used to Help People with Dementia—A Guide for Residents, Families, and Caregivers
Trial the lowest effective dose for the shortest duration. Monitor effectiveness and tolerability using the behaviour and symptom mapping tool
-Behaviour and Symptom Mapping Tool
Collaborate with behavioural support and mental health services
- Explore opportunities to work with an external behavioural support lead, team or champion
Consult Behavioural Supports Ontario or consult with a Geriatric Mental Health Outreach Team or a Psychogeriatric Resource Consultant
Improve staff education and training on dementia
- Educate staff on antipsychotic medications and the behavioural symptoms of dementia
- Train staff to use a person-centred, compassionate, gentle approach to responsive behaviours
Advanced Gerontological Education’s fact sheet on About Gentle Persuasive Approaches in Dementia Care training - Train staff to consistently complete necessary care plan documentation
- Implement protocols and clinical pathways that are in-line with best practice guidelines to clearly guide staff actions
RNAO Best Practice Guidelines
RNAO Clinical Pathways
Last Updated: August 26, 2026